VSPharm Tech
Latest round
- Series B
Last raised
- Sep 2025
Total raised
- $9M
Investors
- 9
About VSPharm Tech
Founded in 2019 and based in Daegu, South Korea, VSPharm Tech operates as a biopharmaceutical company that develops radiotherapy-sensitive drugs to enhance the effectiveness of cancer treatment. VSPharm Tech offers drugs that are sensitive to radiotherapy to improve the effectiveness of cancer treatment based on radiotherapy.
Who invested in VSPharm Tech
9 investors across 5 rounds
See all investors in VSPharm Tech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about VSPharm Tech
Who invested in VSPharm Tech?
VSPharm Tech has 9 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has VSPharm Tech raised?
VSPharm Tech has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did VSPharm Tech last raise money?
VSPharm Tech's most recent round on record is a Series B, in Sep 2025.
What does VSPharm Tech do?
Founded in 2019 and based in Daegu, South Korea, VSPharm Tech operates as a biopharmaceutical company that develops radiotherapy-sensitive drugs to enhance the effectiveness of cancer treatment.
Where is VSPharm Tech headquartered?
VSPharm Tech is headquartered in Daegu, South Korea.
Which VCs invest in companies like VSPharm Tech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at VSPharm Tech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like VSPharm Tech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.